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Abstract: At present, there is poor accuracy in assessing cognitive and
vegetative symptoms in depression using clinician or self-rated measures,
suggesting the need for development of standardized tasks to assess these
functions. The current study assessed the psychometric properties and
diagnostic specificity of a brief neuropsychological screening battery designed
to assess core signs of depression; psychomotor retardation, attention and
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executive functioning difficulties, and impaired emotion perception within an
outpatient psychiatry setting. Three hundred eighty-four patients with mood
disorders and 77 healthy volunteers participated. A large percentage of
patients met diagnostic criteria for Major Depressive Disorder alone (49%) or
with another comorbid psychiatric disorder (24%). A brief, 25-min battery of
computer-based tests was administered to control participants and patients
measuring the constructs of inhibitory control, attention, visual perception,
and both executive and visual processing speed. The patient groups
performed significantly worse than the control group regardless of diagnosis
on visual perception and attention accuracy and processing speed factors.
Surprisingly, the anxiety disorder group performed better than several other
psychiatric disorder groups in inhibitory control accuracy. Developing valid
and reliable measures of cognitive signs in mood disorders creates excellent
opportunities for tracking cognitive status prior to initiation of treatment, and
allows for reliable retest following treatment.
Keywords: Depression, Psychiatric disorders, Executive functioning,
Attention, Affect perception, Cognitive screening, Computers

1. Introduction
The burgeoning field of evidence-based medicine is a catalyst
for the development of objective instruments for diagnosing mental
disorders and tracking symptoms. Cognitive symptoms in mood
disorders such as impairments in attention, concentration, inhibitory
control, psychomotor retardation, affect perception and interpersonal
sensitivity are amenable to evaluation via these methods. Although
computer-based cognitive screening has been increasingly employed in
research (e.g., age-related disorders and head injury), application of
these computer-based screening measures to psychiatric populations
and clinical care has been sparse. The present study provides a
prototype for the use of computer-based cognitive screening measures
that can be administered and scored with minimal utilization of time
and financial resources.
Measurement of specific cognitive deficits in depression and
related disorders poses specific logistical problems when implemented
in a clinical setting. For example, large clinical settings often do not
have technicians (or enough technicians) available to administer
complex, traditional neuropsychological tests, or the investment of
resources needed to administer, score, and interpret these tests.
Computer-based screening batteries, which can be readily translated
for use in a depression clinic, can provide a meaningful, objective
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benchmark to aid psychiatrists and other practitioners in deciding
when a complete neuropsychological evaluation may be needed, or if a
briefer consultation about the cognitive strengths and weaknesses
would be of assistance with diagnosis and treatment (Simpson et al.,
1989; Robbins et al., 1994; Letz et al., 1996a,b; Gur et al., 2001a,b;
Feiger et al., 2003). Many of the previously developed computer-based
batteries used with other populations provide normative data from a
large cohort of individuals, yet none have been specifically designed or
validated for use with depressed patients. For example, batteries
designed for older individuals use paradigms that are often far too
easy, and thus insensitive, to difficulties specific to depression
(Sweeney et al., 2000). In fact, a large number of these paradigms
are used to distinguish between demented elderly and depressed
elderly, with the goal of demonstrating no difficulties in the depressed
elderly, clearly not the ideal parameters for use in psychiatric settings.
Tasks designed for use in a depression clinic must possess adequate
clinical relevance and psychometric accuracy, must be sensitive to
weaknesses reported by patients, and must minimize the
methodological challenges evident in prior research with tasks
developed for use with other populations.
Some existing research suggests a continuum of cognitive
dysfunction in depression and related mood disorders that closely
matches the perceived disease severity, and perhaps the long-term
prognosis of these disorders. For example, attention and executive
functioning deficits noted in bipolar disorder are often more severe
than those observed in unipolar depression (Sweeney et al., 2000;
Borkowska and Rybakowski, 2001). Furthermore, people with anxiety
disorders rarely display any measurable cognitive difficulties, often
outperforming those with other mood disorders and performing
similarly to healthy controls (Gilboa-Schechtman et al., 2002). Some,
however, have failed to demonstrate a distinction between mood
disorders in cognitive functioning, suggesting that there are only small
to modest effect sizes (Hoff et al., 1990; Franke et al., 1993).
Therefore, studies with fewer participants may be underpowered to
detect these differences. Length of illness, genetic predisposition, and
medications may also affect performance on cognitive tests for those
with various mood disorders (Kessing, 1998; Naismith et al., 2003;
Martinez-Aran et al., 2004). Nonetheless, it is reasonable to
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hypothesize that individuals with varying mood disorders may differ by
both the extent and pattern of cognitive difficulty.
The current study presents the psychometric properties and
diagnostic specificity of a brief neuropsychological screening battery
designed to assess core signs of depression; psychomotor retardation,
attention and executive functioning difficulties, and impaired emotion
perception. It was expected that valid, reliable performance could be
obtained on these tests, with factors matching core cognitive
constructs of attention accuracy, inhibitory accuracy, emotion
processing accuracy, and psychomotor speed, and that each derived
factor would demonstrate strong internal reliability. Relationships
between performance and symptoms, length of illness, and diagnostic
subtype were also explored.

2. Methods
2.1. Participants
Consecutive patients (clinic patients, n = 332) arriving for their
first psychiatric appointment with a University of Michigan Depression
Center treatment team were included in the study. Additional research
participants, both control and depressed, were recruited through
projects at the University of Michigan volunteers responding to flyers
posted at the Medical Center (mood disorder patients n = 52, Control
n = 43) and Marquette University college undergraduates receiving
course credit (Control n = 34). As described in detail below, four
control participants and 17 patients did not perform with valid
cognitive data leaving a total of 73 participants in the control group
and 367 participants in the patient group. Only patients and controls
who demonstrated valid data were included in all statistical analyses.
The Institutional Review Boards (IRB) at each respective institution
approved the corresponding study protocol. After complete description
of the study to the participants, written informed consent was obtained
from research participants. Clinic data from patients was deidentified
with an IRB approved waiver of informed consent for this data. The
diagnostic breakdown and demographic characteristics for the
participants are provided in Table 1.
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Table 1. Demographic information for diagnostic groups
Diagnosis code

N/N
valid

%
Female

% Taking
medications

Age

Education

M (S.D.)

M (S.D.)

Major depression
(MDD)

188/179

73.9

60.6

35.5 (12.1)

15.4 (2.8)

MDD and anxiety

62/59

63.0

70.0

35.8 (10.8)

15.5 (2.6)

MDD and dysthymia 29/27

65.6

48.3

35.5 (11.1)

16.2 (2.9)

Dysthymiaa

6/6

83.3

66.7

42.2 (13.8)

16.5 (1.8)

Bipolar

25/24

60.0

96.0

35.8 (9.6)

15.7 (2.8)

Mood disorder

12/11

50.0

50.0

35.6 (14.4)

15.1 (3.6)

Adjustmenta

12/12

83.3

58.3

35.1 (12.5)

15.9 (1.8)

Generalized
anxietyb

19/19

57.9

79.0

36.4 (13.2)

15.0 (3.3)

Obsessive
compulsiveb

5/5

40.0

80.0

36.2 (9.1)

15.6 (1.7)

Panicb

7/7

85.7

62.5

33.1 (10.6)

13.0 (1.9)

Social

phobiab

NOSa

3/3

0.0

66.7

39.3 (19.6)

14.7 (3.1)

Nonea

16/15

68.8

31.3

29.3 (6.8)

14.6 (3.1)

Control

77/73

57.1

0.0

25.1 (9.2)

14.5 (2.5)

Total
461⁎/440 66.1
62.5
33.7 (11.9)
15.3 (2.7)
aIncluded for psychometric analyses, excluded from group analyses due to small
sample size.
bCombined into Anxiety disorder group.
*21 participants data excluded due to performance 2.5 standard deviations below each
group mean on two easy tasks (e.g., Level 1 percent correct targets for the Parametric
Go/No-go task and percent correct animal categorization for the Facial Emotion
Perception Test).

Control participants were screened for depression using the
Hamilton Rating Scale for Depression (HRSD, < 5, Hamilton, 1960,
1967), Beck Depression Inventory-II (BDI, < 6, Beck et al., 1988),
and/or clinical interview. All mood disorder patients were diagnosed
using DSM-IV criteria by board-certified psychiatrists (n = 362) or
using the Structured Clinical Interview for DSM-IV (n = 22, First et al.,
1995). Depression symptoms in clinic patients were assessed with the
Personal Health Questionnaire (Kroenke et al., 2001). Current or past
history of psychological or neurological problems in self or first degree
relatives was ground for exclusion of control participants. Patients
were excluded if there was a current or past diagnosis of psychosis or
neurological disorder, a severe medical disorder that might be
reasonably be expected to impact cognitive functioning (e.g.,
myocardial infarction), or current alcohol or substance
abuse/dependence.
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2.2. Materials
2.2.1. Synonym Knowledge task
The Synonym Knowledge task (SKT; based on Shipley, 1946)
was used as an estimate of verbal intelligence. It was expected that
this would serve as a control task, with no differences between the
groups. Participants were presented with a word and then asked to
choose which of four additional words was most similar in meaning to
the word first presented. There was no penalty for guessing and no
time limit for responding.

2.2.2. Facial Emotion Perception task
The Facial Emotion Perception task (FEPT; Rapport et al., 2002;
Langenecker et al., 2005) was used to assess accuracy and speed of
recognition of facial expressions (e.g., impaired emotion perception)
and animal categorization. The FEPT was used to assess emotion
perception and processing, a domain of decreased functioning in
depression and other mood disorders research (Gur et al., 1992;
Mayberg et al., 1999; LeDoux, 2000). Participants were presented with
and asked to rapidly categorize faces (from Ekman and Friesen, 1976)
and animals. For the face trials, participants categorized the facial
expression into one of four possibilities: happy, sad, angry, or fearful.
For the animal trials, participants categorized the animal into one of
four possibilities: dog, cat, primate, or bird. A stimulus is presented for
300 ms, followed by a mask for 100 ms, and then 2600 ms are
provided as a response window. Trials are separated by the
presentation of a cross for 500 ms.

2.2.3. Parametric Go/No-go task
The Parametric Go/No-go (PGNG) task (Langenecker et al.,
2005, based upon Garavan et al., 1999; Nielson et al., 2002;
Langenecker and Nielson, 2003) was used to assess inhibitory control,
attention and problem-solving abilities (e.g., attention and executive
functioning, see Fig. 1) and associated brain areas also strongly
implicated in depression research (Austin et al., 1999; Bush et al.,
2000; Pizzigalli et al., 2001). The PGNG consist of a rapid
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(interstimulus interval = 500 ms) serial presentation of alphabet
letters, where targets are “x”, “y”, or “z”. In the Go condition (Level
1), the participant is instructed to respond to any of the targets,
regardless of the order of presentation. In the Two-target Go/No-go
condition (Level 2), the participant responds the targets “x” and “y”,
but only in alternation (non-repeating rule, see Fig. 1). The Three
Target Go/No-go task (Level 3) includes all three targets, with the
same non-repeating rule. As such, the working memory load for each
inhibitory condition was minimal (2, 3 targets), while updating of the
to-be-inhibited-target was important, as was control of impulsive
responding to repeating targets. Therefore, two aspects of inhibitory
control are measured (Hasher and Zacks, 1988); behavioral response
inhibition (e.g., impulsivity), and removal inhibition (e.g., updating
working memory rules or set-shifting). Finally, the PGNG provide for
an assessment of psychomotor retardation, with three levels of
cognitive load.

Fig. 1. The Go/No-go task illustration. The non-repeating rule is illustrated for Level 2
and Level 3 Go/No-go, while the Level 1, Go task requires responses to all target
stimuli regardless of order.
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2.3. Procedure
After greeting the participant, an assistant explained that the
project was designed to measure verbal ability, emotion perception,
attention, and inhibition skills. The participant was assured that the
task was not designed for perfect performance, nor was the screen
designed as a thorough measure of cognitive functioning. Once the
participant understood the procedure, the assistant then administered
the three computer-based tasks.

2.4. Statistical analyses
Outliers in the data were truncated using a winsor procedure as
outlined elsewhere (Tabachnik and Fidell, 2001). Descriptive statistics
for the dependent variables were computed, including standard error
of measurement. Groups were compared on demographic factors and
appropriate corrections were made. A chi-square was computed to
determine whether there were a disproportionate number of outlier
data points for patients (n = 367) versus control (n = 73) participants.
A principal axis factor analysis (Control n = 73, Patient n = 367) with
oblique rotation was computed with the executive and emotion
processing dependent variables. Odd-even item reliability (with
Spearman–Brown coefficients) was computed for each of the derived
factors (Control n = 73, Patient n = 367). The relationship between
illness, demographic characteristics and cognitive factors was also
explored. A MANOVA was used to address hypothesized differences on
the cognitive factors between the age-matched control (n = 42) and
mood disorder (n = 367) groups.

3. Results
3.1. Demographic characteristics
The control group did not differ from the patient groups on
education (F = 1.10, df = 12,395, P = 0.31, E2 = 0.032); or estimated
IQ (from SKT, F = 1.16, df = 12,373, P = 0.31, E2 = 0.036). There
were significant differences for age (F = 5.14, df = 12,448,
P < 0.0001, E2 = 0.121); the control group was significantly younger
than the patient groups (all P's < 0.04). There were also more males
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in the control group compared to the entire mood disorder sample
(X¯ = 3.71, n = 461, P = 0.05), although several patient groups had
nearly identical male/female ratios as the control group. The age and
gender differences were controlled for by age-matching groups of
mood disorder and control participants, and by removing a
disproportionate percentage of young males from the sample (e.g.,
18- and 19-year-old males, although some females from this age
range were also removed). As a result, there were no differences
between the age/gender-matched control group and the patient
groups on age (control M = 29.5, S.D. = 9.8, F = 1.48, df = 12,395,
P = 0.13, E2 = 0.043) or gender distribution (73.8% female,
X¯ = 0.53, n = 461, P = 0.46).

3.2. Descriptive statistics and measures of performance
validity
Descriptive statistics are presented for each dependent variable
in Tables 1 and 2. In general, simpler tasks tended to be more
skewed. Validity of performance was determined using outlier criteria
for each group (control, psychiatric separately), a combination of
ascertaining deviance from the mean (e.g., 2.5 S.D.) and taking into
consideration the distribution of scores (e.g., boxplot determination)
on two easy tasks (Level 1 percent correct targets for the PGNG task
and percent correct animal categorization for the Facial Emotion
Perception Test). A chi-square comparing the number of out of range
(e.g., invalid performance) variables between patient (n = 367) and
control (n = 73) groups was not significant (X¯ = 3.47, n = 461,
P = 0.99). The number of valid cases for each group, based upon
psychometric deviance and performance probability on the cognitive
tasks, is presented in Table 1. All participants with valid performance
(n = 440) were used to assess the psychometric properties of the
tasks and relationships with clinical variables (Sections 3.3–3.5), while
only matched control and patient groups with more than 20 subjects
were used to determine any subgroup differences (Section 3.6). Only
the control group matched by age and gender to the patient groups
was used to test this assumption, as age, and possibly gender, could
have a significant impact on performance.
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Table 2. Psychometric statistics for dependent variablesa
Descriptive statistics

M (S.D.)

Min.

Max.

Skewness

Kurtosis

Facial emotion perception task, N = 440
Accuracy
% Correct Animals

92.2 (10.7)

58.0⁎

100.0

− 1.5

1.7

83.5 (10.7)

44.0⁎

100.0

− 1.5

2.5

Animals RT

969.7 (335.1)

402.5⁎ 1846.0⁎ 0.8

0.1

Faces RT

1067.2 (307.3)

422.3

1832.0⁎ 0.7

0.1

1372.8 (454.4)

383.0⁎

2475.0⁎

0.3

− 0.1

80.8 (25.9)

0.0

100.0

− 1.4

1.1

81.9⁎

100.0

− 1.8

2.8

% Correct faces
Response time

Neutral faces RT
Ambiguous stimuli
% Rated negatively

Parametric Go/No-go Task, N = 440
Attention accuracy
Level 1

96.7 (4.6)

Attention, inhibition/updating working memory. Set-shifting, accuracy
Level 2

92.7 (10.3)

61.0⁎

100.0

− 1.8

2.6

Level 3

83.0 (12.6)

46.0⁎

98.1

− 1.0

0.2

79.2 (18.4)

25.0⁎

100.0

− 1.1

0.8

69.4 (18.8)

23.0⁎

100.0

− 0.4

− 0.4

Level 1

461.6 (50.7)

360.3

602.0⁎

0.8

0.5

Level 2

462.7 (67.3)

335.9

649.0⁎

1.0

0.8

354.3

750.0⁎

0.7

0.5

Inhibitory control accuracy
Level 2
Level 3
Response time

Level 3

530.1 (73.2)

Synonym knowledge, N = 383
% Correct
70.5 (13.5)
8.0
95.0
− 1.2
2.5
RT = response time; S.D. = standard deviation; Level 1 = Three-target level of the
Parametric Go/No-go test; Level 2 = two-target level of the Parametric Go/No-go test;
Level 3 = three-target level of the Parametric Go/No-go test.
aValid performance data only.
*Outlier/winsor threshold.

3.3. Factor analysis and reliability
A principal axis factor analysis (control n = 73 and patient
n = 367) with oblique rotation was computed to determine whether
there were separate constructs for emotion processing and executive
functioning. As can be seen in Table 3, a five-factor solution was
extracted. Three of these factors were entirely comprised of the PGNG
variables and the remaining two included facial emotion perception
variables (Table 3). The two processing speed factors (r = 0.42,
P < 0.001) were moderately correlated. As can be seen from the
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correlation matrix included in Table 4, there was little shared variance
in accuracy factors for the Go/No-go and FEPT tasks. Eigenvalues,
variance for each factor (total = 68%), odd–even item reliability and
Spearman–Brown coefficients are included in Table 4. Spearman–
Brown coefficients for four of the five factors (Visual–Perceptual
Processing Speed, Inhibitory Processing Speed, Attention and Set
Shifting Accuracy, Visual–Perceptual Accuracy) ranged from 0.87 to
0.95, with the Inhibitory Accuracy factor coefficient at 0.67. Thus, the
factors match accepted constructs and have good to excellent
reliability.
Table 3. Factor structure for the parametric Go/No-go task and the facial
emotion perception taska
1.

2.

3.

4.

5.

Accuracy (% correctPC)
PC Animals

0.63
(− 0.66)

PC Faces

0.65
(− 0.75)

Level 1 PC Targets

0.39
(0.43)

Level 2 PC Targets

0.39
(0.47)

Level 2 PC Inhibitions

0.48
(0.50)

Level 3 PC Targets

0.81
(0.80)

Level 3 PC Inhibitions

0.59
(0.56)

Neutral stimuli
% Ranked negatively
Response time (RT)
Animals RT

0.74
(0.82)

Faces RT

0.94
(1.00)

Neutral Faces RT

0.65
(0.59)

Level 1 RT

0.63
(0.67)

Level 2 RT

0.84
(0.87)

Level 3 RT

0.96
(0.90)
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Principal Axis Factoring. Oblimin Rotation. 1. Visual–Perceptual Processing Speed, 2.
Inhibitory Processing Speed, 3. Attention Accuracy, 4. Inhibitory Accuracy, 5. Visual–
Perceptual Accuracy. Level 1 = three target Go, Level 2 = two target Go/No-go, Level
3 = three target Go/No-go. Values are factor loadings from the pattern matrix, with
values less than 0.30 are omitted for ease in reading the table. N = 440.
aFactor structure is identical for two (factors 1 and 2 for response time) and three
(factors 3 through 5 for accuracy variables) factor solutions if response time and
accuracy variables are entered separately. Loadings from the two separate factor
analyses are included in parentheses for comparison.

Table 4. Factor correlation matrix, eigenvalues, % variance, and reliability
statistics
Factor
1. Visual–perceptual processing speed

1.
–

2. Inhibitory processing speed

2.

3.

0.42⁎⁎

0.32⁎⁎

–

0.38⁎⁎ 0.01

3. Attention accuracy

–

4. Inhibitory control accuracy

4.
0.11⁎

5.
0.43⁎⁎
0.31⁎⁎

0.15⁎⁎

0.43⁎⁎

–

0.13⁎⁎

5. Visual–perceptual accuracy

–

Factor statistics
Eigenvalues

4.3

1.4

1.2

1.0

% Variance

30.7 11.8

1.7

9.7

8.9

6.9

Spearman–Brown

0.95 0.95

0.94

0.67

0.87

Odd–even r

0.91 0.91

0.88

0.50

0.78

Reliability

*P

< 0.005, ⁎⁎P < 0.0001, N = 440. Odd–even correlations are for odd and even
items from the FEPT and PGNG tasks. % Variance lists the unique variance for each of
the factors derived from the principal axis factor analysis. Spearman–Brown correction
is a correction for split-half reliability, controlling for loss of half of the items in the
scale through odd–even split reliability.

3.4. Clinical characteristics
Both patient groups (i.e., clinic and volunteer patients) had
moderate symptoms of depression (clinic patients n = 317, PHQ-9
M = 13.5, S.D. = 6.3, patient volunteers n = 39, HRSD-17 M = 15.5
and S.D. = 6.2, BDI-II M = 21.3, S.D. = 10.8). When comparing clinic
patients and volunteers with psychiatric illness, the only difference
between the two groups, of all demographic and cognitive variables,
was on the Attention and Set-Shifting Accuracy factor (see below), on
which clinic patients performed significantly worse than the patient
volunteers (F = 5.6, df = 1,401, P = 0.018, E2 = 0.014]. The average
age of onset was 23 years (S.D. = 11.4), with mean symptom
duration of 12.3 years (S.D. = 11.5). Increasing depression symptoms
(BDI-II, HRSD, PHQ-9) were associated with decreased attention and
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set shifting accuracy (BDI-II n = 69, r = − 0.30, P = 0.013, HRSD
n = 72, r = − 0.26, P = 0.026, but not PHQ-9 n = 271, r = − 0.12,
P = 0.053), slower visual processing speed (BDI-II n = 69, r = − 0.28,
P = 0.021, HRSD n = 72, r = − 0.29, P = 0.014, PHQ-9 n = 271,
r = − 0.05, P = 0.384), decreased inhibitory control (PHQ-9 only
n = 271, r = − 0.14, P = 0.027) and slower inhibitory processing
speed (PHQ-9 only n = 271, r = − 0.17, P = 0.005). Age of onset and
years of illness (n = 283 for all correlations) were significantly
correlated with visual spatial accuracy (r = − 0.22, P = 0.0001 and
r = − 0.15, P = 0.014, respectively), visual spatial processing speed
(r = 0.27, P = 0.0001 and r = 0.18, P = 0.002, respectively), and
inhibitory processing speed (r = 0.12, P = 0.038 and r = 0.26,
P = 0.0001, respectively), while attention accuracy was significantly
negatively correlated with years of illness only (r = − 0.04, P = 0.52
and r = − 0.22, P = 0.0001, respectively). No correlations between
symptoms, clinical characteristics and cognitive performance levels
remained significant when age and education were covaried. All factors
except Inhibitory Accuracy (r = 0.00, P = 0.99) were significantly
correlated with age (r's < − 0.24, P's < 0.0001) and all factors except
inhibitory processing speed (r = 0.02, P = 0.68) were significantly
correlated with education (all r's > 0.11, P's < 0.03).

3.5. Medication effects
Differences in psychotropic medication status are noted between
the patient diagnostic groups listed in Table 1 (X¯ = 25.7, n = 384,
P < 0.007). Several groups (Bipolar Disorder 97%, Generalized
Anxiety Disorder 79%, Obsessive Compulsive Disorder 80%, and
Comorbid Depression and Anxiety 66%) were more likely to be taking
psychotropic medications at intake when compared to other groups
(None, 31%, Mood Disorder NOS 50%, Comorbid Depression and
Dysthymia, 48%). Medication-free volunteers were recruited
specifically for one of the research studies. As such, it was expected
that the patient volunteers (54%) would be more likely to be
medication free compared to the clinic patients (36%, X¯ = 6.2,
n = 367, P = 0.01). Medications taken were from 10 different classes
(1. benzodiazepines and similar, 2. opiates, 3. non-opiate pain
medications, 4. stimulants, 5. selective 5HT1 and 5HT2 agents, 6.
selective serotonin and neuroepinephrine re-uptake inhibitors, 7.
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tricyclics, 8. lithium, 9. mood stabilizers, and 10. atypical
antipsychotics). Those patients currently taking medications performed
more poorly only on the Inhibitory Accuracy Factor (t = 2.09,
df = 364, P < 0.04). No differences were found for the other factors
(all t's < 1.5 and P's > 0.15). Future studies with larger sample sizes
are needed to address any cognitive side-effects of medication type as
the current study was underpowered to do so (many patients were
taking multiple medications, confounded by severity and type of
illness—non-random prescriptions).

3.6. Performance differences between mood disorder
and control groups
It was expected that performance differences would exist
between the control (n = 42) group and the diagnostic subgroups
(n = 323). It was also expected that cognitive dysfunction would be
greater in those diagnostic subgroups with more severe mood
disorders (e.g., dual diagnosis, bipolar disorder) as a marker of
psychiatric severity compared to less severe mood disorders. A
MANOVA was computed with diagnostic code as the independent
variable and performance in the respective cognitive factors as
dependent variables. Due to small numbers and lack of differences in
cognitive performance between the anxiety disorder groups (Social
Phobia, Generalized Anxiety, Panic Disorder, and Obsessive
Compulsive Disorder, all F's < 1.34, P's > 0.28), they were combined.
When comparing all the mood groups (MDD, Anxiety, Bipolar,
comorbid MDD/Dysthymia, comorbid MDD/Anxiety) to each other and
to the matched control group, the main effect for cognitive
performance was significant (F = 1.57, P = 0.04, E2 = 0.021). Post hoc
analyses (Fig. 2) indicated that the matched control group performed
better than several patient groups (MDD, P = 0.007, Anxiety
P = 0.052, comorbid MDD/Dysthymia, P = 0.037, and comorbid
MDD/Anxiety, P = 0.026) on Visual–Perception Accuracy and Visual–
Perceptual Processing Speed (MDD, P = 0.027, Bipolar Disorder,
P = 0.016, and comorbid MDD/Anxiety, P = 0.033). For Inhibitory
Control Accuracy, the Anxiety Disorders group performed better than
the Bipolar (P = 0.017) and MDD/Dysthymia (P = 0.028) groups. The
matched control group performed better than all patient groups (all
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P's < 0.003) on Attention and Set-Shifting Accuracy. The cognitive
tests and derived factors selected for this screening battery are
sensitive to attention, executive functioning, emotion processing, and
psychomotor functioning in mood disorders.

Fig. 2. Factor scores for cognitive factors comparing psychiatric subgroups, matched
to control participants. P values are included in parentheses. aThe matched control
group performed better than all patient groups (all P's < 0.003) on the Attention and
Set-Shifting Accuracy factor. bFor the Inhibitory Control Accuracy factor, the Anxiety
Disorders group performed better than the MDD (P = 0.069), Bipolar (P = 0.017), and
MDD/Dysthymia (P = 0.028) groups. cThe comorbid MDD/Anxiety group performed
marginally better than the Bipolar group (P = .088) on the Inhibitory Control factor.
dThe matched control group performed better than all patient groups except the
Bipolar group on the Visual Perception Accuracy Factor (MDD, P = 0.007, Anxiety
P = 0.052, MDD/Dysthymia, P = 0.037, and MDD/Anxiety, P = 0.026). eThe matched
control group performed marginally faster than the MDD (P = 0.077) and the Bipolar
(P = 0.079) groups on the Inhibitory Processing Speed factor. fThe matched control
group also outperformed several patient groups on the Visual–Perceptual Processing
Speed factor (MDD, P = 0.027, Bipolar Disorder, P = 0.016, MDD/Anxiety, P = 0.033).

In order to better test the hypothesis that emotion processing is
impaired in mood disorders, the two variables that comprise the
Visual–Perception Accuracy factor were analyzed in a second posthoc
MANOVA. This MANOVA compared the matched control and different
diagnostic groups with the scores on face emotion and animal
perception as the dependent variables. The control group performed
better than the MDD (P = 0.014, P = 0.033) and comorbid
MDD/dysthymia (P = 0.062, P = 0.088) groups in facial emotion
perception and animal categorization variables, respectively, and
better than the Anxiety (P = 0.026) and comorbid MDD/Anxiety
(P = 0.021) groups in animal categorization.
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4. Discussion
This study demonstrated that, using the present computerbased screening battery, reliable and objective information can be
gathered with fairly minimal investment of time and resources. The
battery was designed specifically for use with a psychiatric population
in an outpatient setting. Therefore, in the future, the battery might be
used as a screening tool in primary psychiatry and family medicine
clinics to indicate who may benefit from a more comprehensive
evaluation. The battery might also be used to determine when
consultations with a neuropsychologist may be beneficial to interpret
poor performance and to assist in managing cognitive weaknesses.
Evaluation of the validity of performance was important, as
concerns about quantifying valid versus invalid data are particularly
salient when employing computer-based cognitive testing (Gur et al.,
2001a,b). Over 95% of participants performed within the valid range
on the FEPT and Go/No-go tasks, supporting the hypothesis that valid
data could be generated using the computer-based battery. As another
mechanism for assessing validity of performance, performance on a
synonym knowledge task was included in the battery (Cohen et al.,
1982; Ellis et al., 1989). As anticipated, the patient and control groups
did not differ on this measure. Similar performance levels on the
synonym knowledge task across groups suggest that effort was
equivalent for these groups as well. This finding is particularly
important given the known performance challenges in depression
(e.g., poor motivation, Rohling et al., 2002). These findings also
suggest that visual motor ability was not the main reason for
differences between groups on the cognitive factors of interest.
A factor analysis was also conducted to determine the nature
and soundness of the psychometric properties of the tasks. It was
expected that the factors would map onto known cognitive constructs
and demonstrate good reliability. From the results, it was clear that
the two primary tasks (Go/No-go and FEPT) were largely independent
of each other in terms of the cognitive substrates underlying
performance. Each of the factors demonstrated moderate to strong
reliability. The relationship between the visual–perceptual accuracy
and attention and set-shifting accuracy factors was modest. Likewise,
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the relationship between response time factors for the Parametric
Go/No-go and Facial Emotion Perception tasks were also modest.
Inverse relationships between response time and accuracy factors for
each of these tasks was in line with standard response time/accuracy
trade-offs (Gur et al., 2001b). Inhibitory accuracy was a highly
independent factor, suggesting that it is not synonymous with
attention or set-shifting skills. Although not within the purview of the
present study, the lack of a significant relationship between the
attention/set-shifting factor and the inhibitory control factor supports
the contention that there are separate executive functions as opposed
to one executive function multiprocessor. In addition, the separation of
attention and inhibitory factors as separate constructs is consistent
with our prior work (Miller et al., 2004).
It was also expected that cognitive dysfunction would exist
along a continuum from no impairment in the control group, mild
dysfunction in the less severe diagnostic subgroups, and more
significant cognitive impairment in persons with more severe
disorders. This hypothesis was not supported as there were cognitive
difficulties in almost all of the patient groups. The executive
functioning and emotion processing difficulties found in MDD, disorders
comorbid with MDD, and Bipolar disorder are consistent with prior
work (Gur et al., 1992, 2001a; Lemelin et al., 1996; Langenecker et
al., 2005). However, closer inspection of Fig. 2 shows that the Bipolar
group was slower and less accurate on the PGNG compared to the
other groups.
One striking result from the present study was the difference in
performance of the anxiety disorders group on inhibitory control
accuracy, on which they outperformed all other groups. Careful
inspection of performance on the attention and inhibitory control
factors suggests that the anxiety disorders group may have been
willing to sacrifice errors of omission to avoid errors of commission,
consistent with prior reports of hypervigilance in this group (Nutt,
2001). This suggests that response profiles may be useful in
distinguishing between persons with primary anxiety and mood
disorders.
Illness and demographic factors were also found to be
associated with cognitive functioning. Most notably, increasing
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symptom severity, age, age of onset, and years of illness were
significantly negatively related to performance on the attention and
set-shifting accuracy factor, consistent with prior cross sectional
results. Slowed processing speed on the FEPT and PGNG were related
with increasing symptom severity and age, but not age of onset or
years of illness. If age is entered as a covariate in partial correlations,
none remained significant, particularly as age of onset and years of
illness are positively related to current age. Studies with larger
samples are needed to better assess age and age of onset confounds
through patient-to-patient matching.
Despite strong interest over the past two decades, findings of
attention and executive functioning difficulties in depression and
related disorders have not been consistently reported (Lemelin et al.,
1996; Schatzberg et al., 2000; Williams et al., 2000; Gotlib et al.,
2004; Langenecker et al., 2005). The present study demonstrates that
on measures of sustained attention and set-shifting, a number of
patient groups performed significantly poorer than the control group. A
recent study has reported decreased behavioral activation in
depressed patients, which might be analogous to the decreased
performance on the attention and set-shifting factor, or target
responses (Kasch et al., 2002). Contrary to expectation, there was
little evidence of difficulties with impulse control in the patient groups
in the present study. Kasch et al. (2002) reported similar findings of
increased behavioral inhibition in patients with depression, which
would likely result in increased inhibitory control performance.
Depression and related disorders have long been viewed as
absent of cognitive impairment and have been traditionally referred to
as “functional” disorders. However, a number of studies, including the
present results, suggest that this view is premature (Hale, 1998;
Dunkin et al., 2000). Many of the measures used in the past as an aid
in screening for dementia were specifically designed to elicit intact
performance in those with mood disorders. Not surprisingly, a number
of these instruments are relatively insensitive to deficits in executive
functioning, attention and emotion perception difficulties in depression
and related groups (Gold et al., 1999; Hobart et al., 1999; Gur et al.,
2001a; Dickerson et al., 2004; Boustani et al., 2005). Furthermore,
many of the previously designed computer-screening measures do not
measure emotion perception and processing, which are rapidly
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emerging as key components of mood disorders and have, along with
executive functioning tasks, been shown to predict treatment response
(Hale, 1998; Dunkin et al., 2000; Kampf-Sherf et al., 2004).
One limitation of the current study was the age difference
between the control group and the patient groups. However, this issue
was addressed by removing a number of the younger control
participants from the analysis and then comparing age-matched
control and patient groups on the cognitive tests. One possible agerelated explanation for the present findings is thus removed by agematching. For example, if unmatched for age, there is the potential for
an interaction between age and psychiatric status to confound the
results of cognitive performance. For example, declines in visual acuity
and visual perceptual abilities are reported with age in older samples
than the current sample (Fisk and Rogers, 1991; Madden et al., 2004;
Cabeza et al., 2004). As there were only 25 participants over the age
of 55, a very conservative threshold for the onset of significant agerelated cognitive decline, there is little to no possibility that age is a
relevant factor in the present results. Some might also consider the
lack of a verbal memory measure in the current study a limitation. The
focus of the current screening measures was on cores signs of
depression, including psychomotor retardation, attention and
executive functioning difficulties, and impaired emotion perception,
rather than verbal memory. However, for additional utility, future
studies might add it into the screening battery.
Another limitation of the present sample is that the patients
were largely selected from a tertiary care clinic and may be more
severe than those seen in regular clinical settings. The average length
of illness for this group was 13 years, which may truly represent a
more chronic, severe sample. Finally, brief batteries such as the one
used in the present sample do not allow for a traditional, more
thorough assessment of multiple cognitive domains. We acknowledge
the tension between speed and breadth, and note that a screening
battery should be sensitive, which appears to be the case here, and
necessarily sacrifices breadth and depth for speed. As a large
percentage of the mood disorders patients exhibited difficulty with
these screening measures, it is likely that few with significant cognitive
difficulties would be missed by such a screen, which is an important
consideration, if beyond the purview of the present study.
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In summary, the present study provides a foundation for future
studies regarding the application of computer-based tasks of cognitive
functioning to mood disorder populations. Computerized tasks can be
administered by technicians and can yield valid data from the vast
majority of participants within clinical and research settings. When
poor performance is evident, the screening data can be sent to a
consulting neuropsychologist to determine if a more thorough
evaluation would be of benefit. Use of a battery of this type effectively
addresses many practical limitations to collecting cognitive screening
data in primary care clinics. Moreover, the present tasks have sound
psychometric properties, including a factor structure that maps onto
both theoretical premises and empirical findings reported in previous
literature. In addition, these tasks demonstrated validity and are
sensitive to attention, executive functioning, and emotion perception
difficulties that were evident in the patient groups. It is possible that
the tasks described in this paper will provide further insight into the
functioning of brain systems known to be affected in mood disorders.
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